TITLE

Tamsulosin increases cataract complications

AUTHOR(S)
Elliott, William T.
PUB. DATE
July 2009
SOURCE
Travel Medicine Advisor;Jul2009 Pharmacology Watch, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses a research being done on tamsulosin, a drug believed to treat benign prostatic hyperlasia (BPH) in older men, who at the same time have undergone cataract surgery. It references a study in Canada where between 2002 to 2007 patients exposed to tamsulosin were found to have more adverse findings than those associated to the drug prior to the operation or to patients given other alpha blockers. The study suggests a reassessment of the observed data for appropriate labeling purposes.
ACCESSION #
41994517

 

Related Articles

  • Alpha-blocker linked to adverse events in cataract surgery.  // Nursing Standard;7/1/2009, Vol. 23 Issue 43, p16 

    The article reports that serious postoperative ophthalmic adverse events are significantly associated with the drug tamsulosin taken within 14 days of cataract surgery. Researchers examined the risk of adverse events after cataract surgery in older men prescribed alpha-blocking drugs such as...

  • CURRENT STATUS OF 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN HYPERPLASIA OF PROSTATE. Kumar, Vijay L.; Wahane, Vishal D. // Indian Journal of Medical Sciences;May2008, Vol. 62 Issue 5, p167 

    Benign prostatic hyperplasia (BPH) is a common problem in aging men, which is associated with lower urinary tract symptoms. This condition is dependent on the presence of androgens for its progression, and medical therapy is the first-line treatment for BPH patients with moderate-to-severe...

  • FDA Actions. Elliott, William T. // Clinical Cardiology Alert;May2010 Pharmacology, p2 

    The article discusses several Food and Drug Administration (FDA) actions, including warnings issued to health care providers regarding the use of antiplatelet drug clopidogrel (Plavix); the approval of Takeda Pharmaceutical’s request to change the name of its proton pump inhibitor...

  • Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Gurbaxani, A.; Packard, R. // Eye;Mar2007, Vol. 21 Issue 3, p331 

    PurposeTo describe the use of intracameral phenylephrine to prevent the floppy iris syndrome seen in patients who are on the drug tamsulosin for benign prostatic hypertrophy, during cataract surgery.SettingPrince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire, UK.MethodSeven...

  • InBrief.  // Urology Times;4/15/2014, Vol. 42 Issue 5, p5 

    The article offers news briefs in April 2014 related to urology in the U.S. It reports on the rank of urologists among all specialties for highest average Medicare payments in 2012, based on the data from the Centers for Medicare & Medicaid Services. Meanwhile, an educational update about...

  • Severe hypotension associated with α blocker tamsulosin. Ramirez, Jorge // BMJ: British Medical Journal;11/16/2013, Vol. 347 Issue 7933, p10 

    The author looks at the link between severe hypotension and the selective α adrenergic receptor antagonist (α blocker) tamsulosin. He references a study by Steven T. Bird and colleagues published within the issue on the safety of tamsulosin. He mentions that tamsulosin is the dominant...

  • Alpha blocker useful for non-bacterial prostatitis. Kuznar, Wayne // Urology Times;Sep2002, Vol. 30 Issue 9, p18 

    Discusses the results of a clinical trial evaluating the potential of alpha blockers in treating men with benign prostatic hyperplasia. Improvement of symptoms in men with moderate to severe chronic non-bacterial prostatitis; Patient characteristics; Dosage; Dose response; Rate of adverse events.

  • Is BPH Interrupting Your Daily Activities?: TREATMENT CAN HELP.  // Urology Times;12/1/2006 Modern Health for Men Sup, Vol. 34, p3 

    The article presents the treatment for the benign prostatic hyperplasia (BPH), which is a common disease among 51 to 60-year-old men in the U.S. New drugs have been approved by the Food and Drug Administration which can help men with BPH in relieving their symptoms. The common treatment options...

  • BENÄ°GN PROSTAT HÄ°PERPLAZÄ°SÄ° TEDAVÄ°SÄ°NDE ALFA BLOKER KULLANIMI. ATAN, Ali; ASLAN, Yılmaz; TUNCEL, Altuğ // Turkish Journal of Geriatrics / Türk Geriatri Dergisi;2012, Vol. 15 Issue 2, p237 

    Lower urinary tract symptoms due to benign prostate hyperplasia is a most common urological problem affecting older men. The dynamic and static components in benign prostatic hyperplasia cause the infravesical obstruction and related lower urinary tract symptoms. Nowadays, there are two main...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics